BioInvent Q3 2022: financial position strengthened, projects progressing - Redeye
Redeye comments on BioInvents report for the third quarter, which saw a further strengthening of the financial position and progress in the clinical development programs.
ANNONS
Redeye comments on BioInvents report for the third quarter, which saw a further strengthening of the financial position and progress in the clinical development programs.